Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Verona Pharma Plc ADR (VRNA)

Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,331,825
  • Shares Outstanding, K 80,440
  • Annual Sales, $ 0 K
  • Annual Income, $ -54,370 K
  • EBIT $ -155 M
  • EBITDA $ -155 M
  • 60-Month Beta 0.46
  • Price/Sales 595.66
  • Price/Cash Flow N/A
  • Price/Book 24.62

Options Overview Details

View History
  • Implied Volatility 60.45% ( +3.64%)
  • Historical Volatility 49.85%
  • IV Percentile 17%
  • IV Rank 19.63%
  • IV High 224.47% on 06/10/24
  • IV Low 20.40% on 01/26/24
  • Put/Call Vol Ratio 0.04
  • Today's Volume 1,574
  • Volume Avg (30-Day) 710
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 33,245
  • Open Int (30-Day) 31,263

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.36
  • Number of Estimates 4
  • High Estimate -0.32
  • Low Estimate -0.40
  • Prior Year -0.16
  • Growth Rate Est. (year over year) -125.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.51 +20.02%
on 11/18/24
41.64 -0.53%
on 12/13/24
+4.49 (+12.16%)
since 11/13/24
3-Month
27.54 +50.40%
on 09/27/24
41.64 -0.53%
on 12/13/24
+11.64 (+39.09%)
since 09/13/24
52-Week
11.39 +263.65%
on 05/30/24
41.64 -0.53%
on 12/13/24
+26.30 (+173.94%)
since 12/13/23

Most Recent Stories

More News
Insider Sale: President and CEO of $VRNA (VRNA) Sells 162,800 Shares

DAVID ZACCARDELLI, the President and CEO of $VRNA ($VRNA), sold 162,800 shares of the company on 12-06-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.1%...

VRNA : 41.42 (+5.50%)
Insider Sale: Chief Financial Officer of $VRNA (VRNA) Sells 12,936 Shares

Mark W Hahn, the Chief Financial Officer of $VRNA ($VRNA), sold 12,936 shares of the company on 11-27-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.1%...

VRNA : 41.42 (+5.50%)
Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma

For Immediate ReleaseChicago, IL – October 25, 2024 – Today, Zacks Equity Research discusses Exelixis, Inc, EXEL, Blueprint Medicines BPMC, CRISPR Therapeutics CRSP, Amicus Therapeutics FOLD and Verona...

FOLD : 9.36 (-7.78%)
CRSP : 43.78 (-3.57%)
VRNA : 41.42 (+5.50%)
EXEL : 35.03 (-0.43%)
BPMC : 93.19 (+0.66%)
5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright

It has been a decent year for the biotech industry so far, buoyed by new drug approvals and positive regulatory/pipeline updates. The third-quarter earnings season has just kicked off, with most major...

FOLD : 9.36 (-7.78%)
CRSP : 43.78 (-3.57%)
VRNA : 41.42 (+5.50%)
EXEL : 35.03 (-0.43%)
BPMC : 93.19 (+0.66%)
2 Standout Biotech Stocks With 32% to 63% Upside

A strong pipeline of products could potentially transform these companies, but there are risks.

RNA : 32.49 (-3.76%)
$SPX : 6,051.09 (unch)
BMY : 55.78 (-0.89%)
VRNA : 41.42 (+5.50%)
3 Healthcare Stocks That Have Outperformed Nvidia Since 2022

The healthcare sector is no slouch when it comes to top-performing growth stocks.

NVDA : 134.25 (-2.25%)
TMDX : 64.26 (-2.21%)
LLY : 789.12 (+0.87%)
VRNA : 41.42 (+5.50%)
3 Stocks That Could Be Monster Winners in 2024

Don't be surprised if these three stocks take off in the new year.

CRSP : 43.78 (-3.57%)
MDGL : 304.50 (+0.67%)
VRNA : 41.42 (+5.50%)
Lucid Is Revving Up, but This Nasdaq Stock Is Jumping Even More

Investors hoped for a rebound in the stock market, but they might have to settle for gains in these two stocks.

COMP : 6.77 (-1.88%)
$NASX : 19,926.72 (+0.12%)
LCID : 2.58 (+1.57%)
VRNA : 41.42 (+5.50%)
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers

Small-cap biotech Catalyst Pharmaceuticals has been outperforming the broader market amid earnings and revenue acceleration. It joined the S&P 600 last month.

SPSM : 47.72 (-0.79%)
CPRX : 21.38 (+0.19%)
CG : 52.64 (-0.81%)
APLS : 33.19 (+1.37%)
AERI : 15.25 (+0.07%)
BLTE : 62.34 (-1.63%)
VRNA : 41.42 (+5.50%)
RVNC : 3.08 (-0.32%)
Verona Pharma plc Announces Pricing of Upsized Underwritten Public Offering

LONDON and RALEIGH, N.C., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage...

VRNA : 41.42 (+5.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Verona Pharma plc is a clinical-stage biopharmaceutical company. It researches, discovers and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. Verona Pharma plc is based in London, the United Kingdom.

See More

Key Turning Points

3rd Resistance Point 44.81
2nd Resistance Point 43.23
1st Resistance Point 42.32
Last Price 41.42
1st Support Level 39.83
2nd Support Level 38.25
3rd Support Level 37.34

See More

52-Week High 41.64
Last Price 41.42
Fibonacci 61.8% 30.08
Fibonacci 50% 26.51
Fibonacci 38.2% 22.95
52-Week Low 11.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar